# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-17-001988
Filing Date
2017-02-09
Accepted
2017-02-09 10:11:47
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 424B3 | atrn20170207_424b3.htm | 424B3 | 2267679
2 |  | schulman.jpg | GRAPHIC | 376408
3 |  | a1.jpg | GRAPHIC | 15754
| Complete submission text file | 0001437749-17-001988.txt |  | 2806653

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-213671 | Film No.: 17585227
SIC: 7389 Services-Business Services, NEC